Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (21525)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 15, 2020 (publication date) through Sep 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sarantis P, Koustas E, Papadimitropoulou A, Papavassiliou AG, Karamouzis MV. Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy. World J Gastrointest Oncol 2020; 12(2): 173-181 [PMID: 32104548 DOI: 10.4251/wjgo.v12.i2.173] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v12/i2/173.htm |
| Number | Citing Articles |
| 1 |
Olamide T. Olaoba, Funmilayo C. Ligali, Zaccheaus O. Alabi, Amos O. Akinyemi, Kehinde S. Ayinde. Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1875(1): 188483 doi: 10.1016/j.bbcan.2020.188483
|
| 2 |
Gehan Botrus, Denise Roe, Gayle S. Jameson, Pedro Luiz Serrano Uson Junior, Ronald Lee Korn, Lana Caldwell, Taylor Bargenquast, Max Miller, Erkut Hasan Borazanci. Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Based Chemotherapy and Olaparib. Biomedicines 2022; 10(11): 2705 doi: 10.3390/biomedicines10112705
|
| 3 |
Jihoon Ko, Jiyoung Song, Nakwon Choi, Hong Nam Kim. Patient‐Derived Microphysiological Systems for Precision Medicine. Advanced Healthcare Materials 2024; 13(7) doi: 10.1002/adhm.202303161
|
| 4 |
David L. Saltman, Tyler J. Nielsen, Davide Salina, David R. Hout, Frank B. McMahon, Boris R. Valev, Michael Huk, Pranil K. Chandra, Jeremy Spille, Robert S. Seitz, Brock L. Schweitzer. Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembrolizumab. Therapeutic Advances in Medical Oncology 2021; 13: 175883592110101 doi: 10.1177/17588359211010156
|
| 5 |
Zelin Hou, Fengchun Lu, Jiajing Lin, Yuwei Wu, Linjin Chen, Haizong Fang, Linlin Chen, Shihan Zhang, Heguang Huang, Yu Pan. Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway. Journal for ImmunoTherapy of Cancer 2024; 12(9): e009318 doi: 10.1136/jitc-2024-009318
|
| 6 |
Pipit Burasakarn, Kwanchanok Yochum, Sermsak Hongjinda, Anuparp Thienhiran, Pusit Fuengfoo. Analysis of risk factors associated with distant metastasis detected at laparotomy in patients with radiologically resectable pancreatic ductal adenocarcinoma. Surgical Practice 2024; 28(2): 76 doi: 10.1111/1744-1633.12669
|
| 7 |
Shantel Angstadt, Qingfeng Zhu, Elizabeth M. Jaffee, Douglas N. Robinson, Robert A. Anders. Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical Implications. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.809179
|
| 8 |
Yijie Ma, Yiwen Yang, Huizhi Zhang, Joseph Mugaanyi, Yangke Hu, Shengdong Wu, Caide Lu, Shuqi Mao, Ke Wang. Sarcomatoid carcinoma of the pancreas (Review). Oncology Letters 2024; 28(4) doi: 10.3892/ol.2024.14610
|
| 9 |
Daniel G. Chen, Jingyi Xie, Jongchan Choi, Rachel H. Ng, Rongyu Zhang, Sarah Li, Rick Edmark, Hong Zheng, Ben Solomon, Katie M. Campbell, Egmidio Medina, Antoni Ribas, Purvesh Khatri, Lewis L. Lanier, Philip J. Mease, Jason D. Goldman, Yapeng Su, James R. Heath. Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer. Cell Reports 2024; 43(3): 113872 doi: 10.1016/j.celrep.2024.113872
|
| 10 |
Epiphane K. Silli, Zhenjiang Zheng, Xintao Zhou, Mengfei Li, Jiali Tang, Ruizhe Guo, Chunlu Tan, Ying Wang. Design optimization of Fucoidan-coating Cationic Liposomes for enhance Gemcitabine delivery. Investigational New Drugs 2024; doi: 10.1007/s10637-024-01455-x
|
| 11 |
Varintra E. Lander, Jad I. Belle, Natalie L. Kingston, John M. Herndon, Graham D. Hogg, Xiuting Liu, Liang-I Kang, Brett L. Knolhoff, Savannah J. Bogner, John M. Baer, Chong Zuo, Nicholas C. Borcherding, Daniel P. Lander, Cedric Mpoy, Jalen Scott, Michael Zahner, Buck E. Rogers, Julie K. Schwarz, Hyun Kim, David G. DeNardo. Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade. Cancer Discovery 2022; 12(12): 2774 doi: 10.1158/2159-8290.CD-22-0192
|
| 12 |
Gyuntae Bae, Georgy Berezhnoy, Alejandra Flores, Claire Cannet, Hartmut Schäfer, Marc H. Dahlke, Patrick Michl, Markus W. Löffler, Alfred Königsrainer, Christoph Trautwein. Quantitative Metabolomics and Lipoprotein Analysis of PDAC Patients Suggests Serum Marker Categories for Pancreatic Function, Pancreatectomy, Cancer Metabolism, and Systemic Disturbances. Journal of Proteome Research 2024; 23(4): 1249 doi: 10.1021/acs.jproteome.3c00611
|
| 13 |
Geou-Yarh Liou, Crystal J. Byrd. Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need. Cancers 2023; 15(9): 2446 doi: 10.3390/cancers15092446
|
| 14 |
Kateřina Novotná, Lukáš Tenora, Barbara S. Slusher, Rana Rais. The Discovery of New Medicines in Academia. Advances in Pharmacology 2024; 100: 157 doi: 10.1016/bs.apha.2024.04.003
|
| 15 |
Adi Jabarin, Guy Shtar, Valeria Feinshtein, Eyal Mazuz, Bracha Shapira, Shimon Ben-Shabat, Lior Rokach. Eravacycline, an antibacterial drug, repurposed for pancreatic cancer therapy: insights from a molecular-based deep learning model. Briefings in Bioinformatics 2024; 25(3) doi: 10.1093/bib/bbae108
|
| 16 |
Allison A Fitzgerald, Shangzi Wang, Veena Agarwal, Emily F Marcisak, Annie Zuo, Sandra A Jablonski, Melanie Loth, Elana J Fertig, John MacDougall, Eugene Zhukovsky, Shubhendu Trivedi, Dimple Bhatia, Vince O'Neill, Louis M Weiner. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma. Journal for ImmunoTherapy of Cancer 2021; 9(11): e002837 doi: 10.1136/jitc-2021-002837
|
| 17 |
V. S. Tikhonova, I. S. Gruzdev, E. V. Kondratyev, K. A. Mikhaylyuk, G. G. Kаrmаzаnovsky. Texture analysis of contrast enhancement СT in the differential diagnosis of mass-forming pancreatitis and pancreatic ductal adenocarcinoma. Medical Visualization 2022; doi: 10.24835/1607-0763-1068
|
| 18 |
Yi-Ping Huang, Te-Chun Hsia, Chun-An Yeh, Yi-Shih Ma, Sheng-Yao Hsu, Yi-Chung Liu, Ping-Chiang Lyu, Kuang-Chi Lai, Shu-Fen Peng, Jin-Cherng Lien, Wen-Tsong Hsieh, Helena Moreira. PW06 Triggered Fas-FADD to Induce Apoptotic Cell Death In Human Pancreatic Carcinoma MIA PaCa-2 Cells through the Activation of the Caspase-Mediated Pathway. Oxidative Medicine and Cellular Longevity 2023; 2023: 1 doi: 10.1155/2023/3479688
|
| 19 |
Mayank Baranwal, Santhoshi Krishnan, Morgan Oneka, Timothy Frankel, Arvind Rao. CGAT: Cell Graph ATtention Network for Grading of Pancreatic Disease Histology Images. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.727610
|
| 20 |
Graziana Digiacomo, Francesco Volta, Ingrid Garajova, Rita Balsano, Andrea Cavazzoni. Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC. Life 2021; 11(8): 843 doi: 10.3390/life11080843
|
| 21 |
Kritisha Bhandari, Wei-Qun Ding. Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy. International Journal of Molecular Sciences 2024; 25(7): 3958 doi: 10.3390/ijms25073958
|
| 22 |
Omar F. Luna, Yomkippur V. Perez, Daniele P. Ferrari, Sana S. Sayedipour, Miriam Royo, Gerardo A. Acosta, Luis J. Cruz, Frauke Alves, Erik Agner, Magne O. Sydnes, Fernando Albericio. Impact of N-Terminal PEGylation on Synthesis and Purification of Peptide-Based Cancer Epitopes for Pancreatic Ductal Adenocarcinoma (PDAC). ACS Omega 2024; 9(32): 34544 doi: 10.1021/acsomega.4c02604
|
| 23 |
Pankti C. Balar, Vasso Apostolopoulos, Vivek P. Chavda. A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way. European Journal of Pharmacology 2024; 969: 176451 doi: 10.1016/j.ejphar.2024.176451
|
| 24 |
Cristina Mosconi, Maria Adriana Cocozza, Filippo Piacentino, Federico Fontana, Alberta Cappelli, Francesco Modestino, Andrea Coppola, Diego Palumbo, Paolo Marra, Paola Maffi, Lorenzo Piemonti, Antonio Secchi, Claudio Ricci, Riccardo Casadei, Gianpaolo Balzano, Massimo Falconi, Giulio Carcano, Antonio Basile, Anna Maria Ierardi, Gianpaolo Carrafiello, Francesco De Cobelli, Rita Golfieri, Massimo Venturini. Interventional Radiological Management and Prevention of Complications after Pancreatic Surgery: Drainage, Embolization and Islet Auto-Transplantation. Journal of Clinical Medicine 2022; 11(20): 6005 doi: 10.3390/jcm11206005
|
| 25 |
Adib Miraki Feriz, Arezou Khosrojerdi, Nafiseh Erfanian, Setareh Azarkar, Seyed Mehdi Sajjadi, Mohammad Javad Shojaei, Mohammad Javad Vaferi, Hossein Safarpour, Vito Racanelli. Targeting the dynamic transcriptional landscape of Treg subpopulations in pancreatic ductal adenocarcinoma: Insights from single-cell RNA sequencing analysis with a focus on CTLA4 and TIGIT. Immunobiology 2024; 229(4): 152822 doi: 10.1016/j.imbio.2024.152822
|
| 26 |
Benedetta Ferrara, Erica Dugnani, Antonio Citro, Marco Schiavo Lena, Paolo Marra, Paolo Riccardo Camisa, Martina Policardi, Tamara Canu, Antonio Esposito, Claudio Doglioni, Lorenzo Piemonti. ASO Author Reflections: Bridging the Gap in PDAC Research: The Intraportal Model as a Platform for Studying Preclinical Liver Metastasis. Annals of Surgical Oncology 2024; doi: 10.1245/s10434-024-15655-5
|
| 27 |
Dilara Aylar, Ayse Karatug Kacar. Studies on Treatment Within the Scope of Medical Biotechnology for Pancreatic Diseases. Molecular Biotechnology 2024; doi: 10.1007/s12033-024-01142-5
|
| 28 |
Mustafa B. A. Djamgoz, Valerie Jentzsch. Integrative Management of Pancreatic Cancer (PDAC): Emerging Complementary Agents and Modalities. Nutrition and Cancer 2022; 74(4): 1139 doi: 10.1080/01635581.2021.1934043
|
| 29 |
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, Giulia Mantini, Fatemeh Khojasteh-Leylakoohi, Annalisa Comandatore, Ghazaleh Khalili-Tanha, Alireza Khooei, Luca Morelli, Amir Avan, Erik H. Danen, Thomas Schmidt, Elisa Giovannetti. Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC). Cancers 2023; 15(3): 628 doi: 10.3390/cancers15030628
|
| 30 |
Antonella Farina, Sara Tartaglione, Adele Preziosi, Patrizia Mancini, Antonio Angeloni, Emanuela Anastasi. PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDAC. International Journal of Molecular Sciences 2024; 25(6): 3498 doi: 10.3390/ijms25063498
|
| 31 |
Sophia Tsokkou, Ioannis Konstantinidis, Maria-Nefeli Georgaki, Dimitrios Kavvadas, Kyriaki Papadopoulou, Antonios Keramas, Antonia Sioga, Theodora Papamitsou, Sofia Karachrysafi. Gestational Diabetes Mellitus and Its Correlation in the Development of Pancreatic Cancer: A 10-Year Systematic Review. Cancers 2024; 16(10): 1840 doi: 10.3390/cancers16101840
|
| 32 |
Tingting Xu, Xiaoxuan Xu, Lijiao Yang, Xiaoyuan Chen, Shenghong Ju. Noninvasive Visualization of Obesity-Boosted Inflammation in Orthotopic Pancreatic Ductal Adenocarcinoma Using an Octapod Iron Oxide Nanoparticle. ACS Applied Bio Materials 2020; 3(9): 6408 doi: 10.1021/acsabm.0c00841
|
| 33 |
Fan Zhang, Xiaomin Li, Haisheng Liu, Rongfeng Liu, Zhiguo Zhou, Yi Zhang, Jingli Chen, Ye Tian, Chaohu Pan, Qingju Meng, Yibing Liu. Unexpected favorable outcome to sintilimab monotherapy in a relapse pancreatic ductal adenocarcinoma patient with high tumor mutational burden: a case report. Anti-Cancer Drugs 2022; 33(9): 975 doi: 10.1097/CAD.0000000000001334
|
| 34 |
Kendelle J. Murphy, Jessie Zhu, Michael Trpceski, Brooke A. Pereira, Paul Timpson, David Herrmann. Focal adhesion kinase priming in pancreatic cancer, altering biomechanics to improve chemotherapy. Biochemical Society Transactions 2022; 50(4): 1129 doi: 10.1042/BST20220162
|
| 35 |
Anastasios Gkountakos, Michele Simbolo, Elena Bariani, Aldo Scarpa, Claudio Luchini. Undifferentiated Sarcomatoid Carcinoma of the Pancreas: From Histology and Molecular Pathology to Precision Oncology. International Journal of Molecular Sciences 2022; 23(3): 1283 doi: 10.3390/ijms23031283
|
| 36 |
Hassan Aziz, Ye In Christopher Kwon, Andrew Min-Gi Park, Alan Lai, Kerry Yi Chen Lee, Dean Zhang, Yeseo Kwon, Timothy M. Pawlik. Recent advancements in management for noncolorectal, nonneuroendocrine hepatic metastases. Journal of Gastrointestinal Surgery 2024; doi: 10.1016/j.gassur.2024.08.012
|
| 37 |
Hanqing Wu, Bo Wang, Li Wang, Yinkai Xue. circular RNAs 0000515 and 0011385 as potential biomarkers for disease monitoring and determining prognosis in pancreatic ductal adenocarcinoma. Oncology Letters 2021; 23(2) doi: 10.3892/ol.2021.13174
|
| 38 |
Shazia Asghar, Shahid Hameed, Najim A Al‐Masoudi, Bahjat Saeed, Amneh Shtaiwi. Design, Synthesis, Docking Studies and Molecular Dynamics Simulation of New 1,3,5‐Triazine Derivatives as Anticancer Agents Selectively Targeting Pancreatic Adenocarcinoma (Capan‐1). Chemistry & Biodiversity 2024; 21(5) doi: 10.1002/cbdv.202400112
|
| 39 |
Michael S. Nelson, Yuming Liu, Helen M. Wilson, Bin Li, Ivan M. Rosado-Mendez, Jeremy D. Rogers, Walter F. Block, Kevin W. Eliceiri. The Tumor Microenvironment. Methods in Molecular Biology 2023; 2614: 187 doi: 10.1007/978-1-0716-2914-7_13
|
| 40 |
Rodrigo Paredes de la Fuente, Santiago Sucre, Cristina Ponce, Ahmed Anwer Ali Rattani, Mary Linton B. Peters. Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel. Cancers 2024; 16(15): 2734 doi: 10.3390/cancers16152734
|
| 41 |
Sooin Byeon, Taymin du Toit‐Thompson, Josef Gillson, Anthony J. Gill, Jaswinder S. Samra, Anubhav Mittal, Sumit Sahni. Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis. Cancer Medicine 2023; 12(17): 18020 doi: 10.1002/cam4.6407
|
| 42 |
Davide Busato, Monica Mossenta, Michele Dal Bo, Paolo Macor, Giuseppe Toffoli. The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2022; 23(18): 10279 doi: 10.3390/ijms231810279
|
| 43 |
Happy Agarwal, Ryan C. Bynum, Nada Saleh, Danielle Harris, William M. MacCuaig, Vung Kim, Emma J. Sanderson, Isabel S. Dennahy, Rohit Singh, Bahareh Behkam, Jorge G. Gomez‐Gutierrez, Ajay Jain, Barish H. Edil, Lacey R. McNally. Theranostic nanoparticles for detection and treatment of pancreatic cancer. WIREs Nanomedicine and Nanobiotechnology 2024; 16(4) doi: 10.1002/wnan.1983
|
| 44 |
Panagiotis Sarantis, Alexandros Bokas, Adriana Papadimitropoulou, Evangelos Koustas, Stamatios Theocharis, Pavlos Papakotoulas, Dimitrios Schizas, Alexandros Papalampros, Evangelos Felekouras, Athanasios G. Papavassiliou, Michalis V. Karamouzis. Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(13): 7053 doi: 10.3390/ijms22137053
|
| 45 |
Casper W.F. van Eijck, Willem de Koning, Fleur van der Sijde, Miranda Moskie, Bas Groot Koerkamp, Marjolein Y.V. Homs, Sjoerd H. van der Burg, Casper H.J. van Eijck, Dana A.M. Mustafa. A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma. European Journal of Cancer 2023; 181: 119 doi: 10.1016/j.ejca.2022.12.024
|
| 46 |
Zachary Hamel, Sierra Sanchez, David Standing, Shrikant Anant. Role of STAT3 in pancreatic cancer. Exploration of Targeted Anti-tumor Therapy 2024; 5(1): 20 doi: 10.37349/etat.2024.00202
|
| 47 |
Masato Kamakura, Takeshi Uehara, Mai Iwaya, Shiho Asaka, Shota Kobayashi, Tomoyuki Nakajima, Yasuhiro Kinugawa, Tadanobu Nagaya, Takahiro Yoshizawa, Akira Shimizu, Hiroyoshi Ota, Takeji Umemura. LGR5 expression and clinicopathological features of the invasive front in the fat infiltration area of pancreatic cancer. Diagnostic Pathology 2022; 17(1) doi: 10.1186/s13000-022-01203-w
|
| 48 |
Jin-Lei Wang, Xiang Li, Jia-Ru Fan, Jia-Ping Yan, Ze-Mao Gong, Yue Zhao, Dong-Mei Wang, Li Ma, Na Ma, Diao-Mei Guo, Lian-Sheng Ma. Integrity of the editing and publishing process is the basis for improving an academic journal’s Impact Factor. World Journal of Gastroenterology 2022; 28(43): 6168-6202 doi: 10.3748/wjg.v28.i43.6168
|
| 49 |
Ben O’Leary, Heath Skinner, Jonathan D Schoenfeld, Lisa Licitra, Christophe Le Tourneau, Christina Esdar, Andreas Schroeder, Satu Salmio, Amanda Psyrri. Evasion of apoptosis and treatment resistance in squamous cell carcinoma of the head and neck. Cancer Treatment Reviews 2024; 129: 102773 doi: 10.1016/j.ctrv.2024.102773
|
| 50 |
Abigail C. Cornwell, Arwen A. Tisdale, Swati Venkat, Kathryn E. Maraszek, Abdulrahman A. Alahmari, Anthony George, Kristopher Attwood, Madison George, Donald Rempinski, Janusz Franco-Barraza, Mukund Seshadri, Mark D. Parker, Eduardo Cortes Gomez, Christos Fountzilas, Edna Cukierman, Nina G. Steele, Michael E. Feigin. Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer. Clinical Cancer Research 2023; 29(18): 3793 doi: 10.1158/1078-0432.CCR-23-0547
|
| 51 |
Yalçın ERZURUMLU. Katlanmamış Protein Yanıtı Sinyal Yolunun IRE1α Kolunun Baskılanmasının PANC-1 Pankreatik Duktal Adenokarsinoma Hücrelerinin Tümörijenik Özellikleri Üzerindeki Etkilerinin İncelenmesi. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi 2022; 13(1): 11 doi: 10.22312/sdusbed.1003140
|
| 52 |
Gitika Thakur, Raj Kumar, Saet-Byul Kim, Sang-Yeob Lee, Sung-Lim Lee, Gyu-Jin Rho. Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma. Biomedicines 2021; 9(2): 178 doi: 10.3390/biomedicines9020178
|
| 53 |
Aaron Galindo-Vega, Vilma Maldonado-Lagunas, Irma B. Mitre-Aguilar, Jorge Melendez-Zajgla. Tumor Microenvironment Role in Pancreatic Cancer Stem Cells. Cells 2023; 12(12): 1560 doi: 10.3390/cells12121560
|
| 54 |
Simran Arjani, Pedro F Saint-Maurice, Sachelly Julián-Serrano, Guido Eibl, Rachael Stolzenberg-Solomon. Body Mass Index Trajectories Across the Adult Life Course and Pancreatic Cancer Risk. JNCI Cancer Spectrum 2022; 6(6) doi: 10.1093/jncics/pkac066
|
| 55 |
Gurkaranjot Singh, Drew Kutcher, Rajeshwar Lally, Vikrant Rai. Targeting Neoantigens in Pancreatic Ductal Adenocarcinoma. Cancers 2024; 16(11): 2101 doi: 10.3390/cancers16112101
|
| 56 |
H Shafeeq AHMED. BEYOND TRADITIONAL TOOLS: EXPLORING CONVOLUTIONAL NEURAL NETWORKS AS INNOVATIVE PROGNOSTIC MODELS IN PANCREATIC DUCTAL ADENOCARCINOMA. Arquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612023-117
|
| 57 |
Sandeep Singh, Rajeev Kumar Sharma, R. Ramajayam. Bis-pyrazole as receptor interacting protein 1 kinase inhibitor: Synthesis, preliminary biological evaluation against pancreatic cancer cell line and its docking studies. Results in Chemistry 2024; 7: 101447 doi: 10.1016/j.rechem.2024.101447
|
| 58 |
Donatella Delle Cave. Emerging Therapeutic Options in Pancreatic Cancer Management. International Journal of Molecular Sciences 2024; 25(3): 1929 doi: 10.3390/ijms25031929
|
| 59 |
Gehan Botrus, Richard M. Miller, Pedro Luiz Serrano Uson Junior, Geoffrey Kannan, Haiyong Han, Daniel D. Von Hoff. Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR). International Journal of Molecular Sciences 2022; 24(1): 577 doi: 10.3390/ijms24010577
|
| 60 |
Carla Mottini, Luca Cardone. Beyond the Genomic Mutation: Rethinking the Molecular Biomarkers of K-RAS Dependency in Pancreatic Cancers. International Journal of Molecular Sciences 2020; 21(14): 5023 doi: 10.3390/ijms21145023
|
| 61 |
Friederike V. Opitz, Lena Haeberle, Alexandra Daum, Irene Esposito. Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia. Cancers 2021; 13(24): 6188 doi: 10.3390/cancers13246188
|
| 62 |
Priyanka Narad, Romasha Gupta, Sudeepti Kulshrestha, Abhishek Sengupta. Systems Biology Approaches: Prevention, Diagnosis, and Understanding Mechanisms of Complex Diseases. 2024; : 437 doi: 10.1007/978-981-99-9462-5_17
|
| 63 |
Julien Taieb, Thomas Seufferlein, Michele Reni, Daniel H. Palmer, John A. Bridgewater, Antonio Cubillo, Gerald W. Prager, Alice Vermeire, Fabienne Hédouin-Biville, Zhaoyang Teng, Teresa Macarulla. Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11377-1
|
| 64 |
Nagabhishek Sirpu Natesh, Brianna M. White, Maia M. C. Bennett, Metin Uz, Rakhee Rathnam Kalari Kandy, Surinder K. Batra, Surya K. Mallapragada, Satyanarayana Rachagani. Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers. Pharmaceutics 2021; 13(12): 1987 doi: 10.3390/pharmaceutics13121987
|
| 65 |
Joanna Jazowiecka-Rakus, Aleksander Sochanik, Agata Hadryś, Wojciech Fidyk, Ewa Chmielik, Masmudur M. Rahman, Grant McFadden. Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma. Cancers 2022; 14(8): 2022 doi: 10.3390/cancers14082022
|
| 66 |
Panagiotis Sarantis, Michalis V. Karamouzis. The impact of thromboprophylaxis with LMWHs on the survival of patients with pancreatic cancer. Thrombosis Research 2022; 213: S120 doi: 10.1016/j.thromres.2022.02.004
|
| 67 |
Shuai Liu, Hua Zhong, Jingjing Zhu, Yong Wu, Youping Deng, Lang Wu. Regulome‐wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk. International Journal of Cancer 2024; 154(4): 670 doi: 10.1002/ijc.34761
|
| 68 |
Marzia Conte, Valentina Cauda. Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments. Advanced Therapeutics 2022; 5(11) doi: 10.1002/adtp.202200079
|
| 69 |
Macy Marie Payne, Ivina Mali, Tej B. Shrestha, Matthew T. Basel, Sarah Timmerman, Marla Pyle, Jan Sebek, Punit Prakash, Stefan H. Bossmann. T1-mapping characterization of two tumor types. Biophysical Reports 2024; 4(2): 100157 doi: 10.1016/j.bpr.2024.100157
|
| 70 |
Shruti Gupta, Atul Kumar, Kiran Kumar Tejavath. Unfolding antifungals: as a new foe to pancreatic ductal adenocarcinoma—a mini-review. Molecular Biology Reports 2021; 48(3): 2945 doi: 10.1007/s11033-021-06318-9
|
| 71 |
Reetu Mukherji, Ali Alqahtani, Harrison D Winters, Benjamin A Weinberg. Use of Circulating Tumour DNA to Assess Minimal Residual Disease in Gastrointestinal Cancers. Oncology & Haematology 2022; 18(1): 26 doi: 10.17925/OHR.2022.18.1.26
|
| 72 |
Stavros P. Papadakos, Nikolaos Dedes, Nikolina Gkolemi, Nikolaos Machairas, Stamatios Theocharis. The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment. International Journal of Molecular Sciences 2023; 24(3): 3015 doi: 10.3390/ijms24033015
|
| 73 |
Faithlore P. Gardner, Zev A. Wainberg, Christos Fountzilas, Nathan Bahary, Mark S. Womack, Teresa Macarulla, Ignacio Garrido-Laguna, Patrick M. Peterson, Erkut Borazanci, Melissa Johnson, Matteo Ceccarelli, Uwe Pelzer. Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer. Cancers 2024; 16(7): 1323 doi: 10.3390/cancers16071323
|
| 74 |
Yukun Huang, Yu Chen, Songlei Zhou, Laozhi Xie, Kaifan Liang, Jianpei Xu, Qian Zhang, Huan Chen, Dayuan Wang, Qingxiang Song, Gan Jiang, Ni Mei, Fenfen Ma, Huiping Lu, Xiaoling Gao, Jun Chen. Synthetically Lethal Biomimetic Nutri-hijacker Hitchhikes and Reprograms KRAS Mutation-Driven Metabolic Addictions for Pancreatic Ductal Adenocarcinoma Treatment. ACS Nano 2023; 17(14): 14014 doi: 10.1021/acsnano.3c04069
|
| 75 |
Ana Bogut, Bojan Stojanovic, Marina Jovanovic, Milica Dimitrijevic Stojanovic, Nevena Gajovic, Bojana S. Stojanovic, Goran Balovic, Milan Jovanovic, Aleksandar Lazovic, Milos Mirovic, Milena Jurisevic, Ivan Jovanovic, Violeta Mladenovic. Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities. International Journal of Molecular Sciences 2023; 24(21): 15500 doi: 10.3390/ijms242115500
|
| 76 |
Mahmut Mijit, Randall Wireman, Lee Armstrong, Silpa Gampala, Zonera Hassan, Christian Schneeweis, Guenter Schneider, Chi Zhang, Melissa L. Fishel, Mark R. Kelley. RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.826617
|
| 77 |
Yong-Qiang Hua, Ke Zhang, Jie Sheng, Zhou-Yu Ning, Ye Li, Wei-dong Shi, Lu-Ming Liu. NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolded Protein Response. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.641836
|
| 78 |
Sofia M. Sousa, Helena Branco, Amir Avan, Andreia Palmeira, Luca Morelli, Lúcio L. Santos, Elisa Giovannetti, M. Helena Vasconcelos, Cristina P. R. Xavier. Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma. Cancer Chemotherapy and Pharmacology 2024; doi: 10.1007/s00280-024-04712-1
|
| 79 |
Spas Dimitrov Markov, Thomas C. Caffrey, Kelly A. O'Connell, James A. Grunkemeyer, Simon Shin, Ryan Hanson, Prathamesh P. Patil, Surendra K. Shukla, Daisy Gonzalez, Ayrianne J. Crawford, Krysten E. Vance, Ying Huang, Kirsten C. Eberle, Prakash Radhakrishnan, Paul M. Grandgenett, Pankaj K. Singh, Ragupathy Madiyalakan, Tracy R. Daniels-Wells, Manuel L. Penichet, Christopher F. Nicodemus, Jill A. Poole, Elizabeth M. Jaffee, Michael A. Hollingsworth, Kamiya Mehla. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer. Molecular Cancer Therapeutics 2021; 20(12): 2457 doi: 10.1158/1535-7163.MCT-21-0368
|
| 80 |
Ghada Salah, Manar Obada, Dina Sweed, Ibrahim Abdelkader Salama, Ashraf Khalil, Shimaa Abdelsattar. Diagnostic and prognostic significance of tissue lncRNA HOTAIR and hexokinase 2 mRNA expression in patients with pancreatic ductal adenocarcinoma. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-023-00308-1
|
| 81 |
Lei Feng, Xiaojuan Tang, Zhen You. Undifferentiated sarcomatoid carcinoma of the pancreas-a single-institution experience with 23 cases. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-11988-2
|
| 82 |
Gonçalo Mesquita, Aurélien Haustrate, Adriana Mihalache, Benjamin Soret, Clément Cordier, Emilie Desruelles, Erika Duval, Zoltan Pethö, Natalia Prevarskaya, Albrecht Schwab, V’yacheslav Lehen’kyi. TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics. Cancers 2023; 15(24): 5769 doi: 10.3390/cancers15245769
|
| 83 |
Nnenna Elebo, Mafuno Grace Mpinganjira, Pavan Baichan, John Devar, Jones Omoshoro-Jones, Joel Msafiri Francis, Martin Smith, Ekene Emmanuel Nweke. The need for research targeting the link between occupational carcinogens and hepatopancreatobiliary cancers in Africa: A systematic review. Translational Oncology 2024; 47: 102036 doi: 10.1016/j.tranon.2024.102036
|
| 84 |
Benedetta Ferrara, Erica Dugnani, Antonio Citro, Marco Schiavo Lena, Paolo Marra, Paolo Riccardo Camisa, Martina Policardi, Tamara Canu, Antonio Esposito, Claudio Doglioni, Lorenzo Piemonti. Establishment of a Transplantation Model of PDAC-Derived Liver Metastases. Annals of Surgical Oncology 2024; 31(9): 6138 doi: 10.1245/s10434-024-15514-3
|
| 85 |
Simona Carlomagno, Chiara Setti, Fulvia Ortolani, Simona Sivori. Pancreatic ductal adenocarcinoma microenvironment: Soluble factors and cancer associated fibroblasts as modulators of NK cell functions. Immunology Letters 2024; 269: 106898 doi: 10.1016/j.imlet.2024.106898
|
| 86 |
Josiah McAllister, Saber Amin, Chi Lin. Association of Facility Type With Overall Survival in Patients with Nonsurgically Managed Pancreatic Cancer. Future Oncology 2022; 18(10): 1273 doi: 10.2217/fon-2021-0986
|
| 87 |
Yixing Kang, Xiangwen Xu, Jikui Liu.
System Analysis Based on Pancreatic Cancer Progression Identifies BRINP2 as a Novel Prognostic Biomarker
. Critical Reviews in Eukaryotic Gene Expression 2023; 33(7): 1 doi: 10.1615/CritRevEukaryotGeneExpr.2023048337
|
| 88 |
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1427802
|
| 89 |
Cesar B. Aparicio-Lopez, Sarah Timmerman, Gabriella Lorino, Tatiana Rogers, Marla Pyle, Tej B. Shrestha, Matthew T. Basel. Thermosensitive Liposomes for Gemcitabine Delivery to Pancreatic Ductal Adenocarcinoma. Cancers 2024; 16(17): 3048 doi: 10.3390/cancers16173048
|
| 90 |
Lei Zhao, Yaming Cao. PD-L1 Expression Level Displays a Positive Correlation with Immune Response in Pancreatic Cancer. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/8843146
|
| 91 |
Alejandro A. Puchol Tarazona, Alexander Schinagl, Irina Mirkina, Gregor Rossmueller, Randolf J. Kerschbaumer, Friedmund Bachmann, Michael Thiele. Pretargeted Radioimmunotherapy with the Novel Anti-oxMIF/HSG Bispecific Antibody ON105 Results in Significant Tumor Regression in Murine Models of Cancer. Molecular Cancer Therapeutics 2024; 23(9): 1219 doi: 10.1158/1535-7163.MCT-24-0083
|
| 92 |
Xue Wang, Zhan Shi, Jiali Luo, Yiqing Zeng, Liangcan He, Libin Chen, Jianting Yao, Tao Zhang, Pintong Huang. Ultrasound improved immune adjuvant delivery to induce DC maturation and T cell activation. Journal of Controlled Release 2022; 349: 18 doi: 10.1016/j.jconrel.2022.06.054
|
| 93 |
Salomé Araujo-Abad, Antonio Manresa-Manresa, Enrique Rodríguez-Cañas, María Fuentes- Baile, Pilar García-Morales, Ricardo Mallavia, Miguel Saceda, Camino de Juan Romero. New therapy for pancreatic cancer based on extracellular vesicles. Biomedicine & Pharmacotherapy 2023; 162: 114657 doi: 10.1016/j.biopha.2023.114657
|
| 94 |
Bahareh Hassani, Zeinab Attar, Negar Firouzabadi. The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03080-9
|
| 95 |
Karel Hořejší, Chunsheng Jin, Zuzana Vaňková, Robert Jirásko, Ondřej Strouhal, Bohuslav Melichar, Susann Teneberg, Michal Holčapek. Comprehensive characterization of complex glycosphingolipids in human pancreatic cancer tissues. Journal of Biological Chemistry 2023; 299(3): 102923 doi: 10.1016/j.jbc.2023.102923
|
| 96 |
Milica Dimitrijevic Stojanovic, Bojan Stojanovic, Ivan Radosavljevic, Vojin Kovacevic, Ivan Jovanovic, Bojana S. Stojanovic, Nikola Prodanovic, Vesna Stankovic, Miodrag Jocic, Marina Jovanovic. Galectin-3’s Complex Interactions in Pancreatic Ductal Adenocarcinoma: From Cellular Signaling to Therapeutic Potential. Biomolecules 2023; 13(10): 1500 doi: 10.3390/biom13101500
|
| 97 |
Emily A. Henderson, Abby Ivey, Soo Jeon Choi, Stell Santiago, Dudley McNitt, Tracy W. Liu, Slawomir Lukomski, Brian A. Boone. Group A streptococcal collagen-like protein 1 restricts tumor growth in murine pancreatic adenocarcinoma and inhibits cancer-promoting neutrophil extracellular traps. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1363962
|
| 98 |
Changhoon Yoo, Angela Lamarca, Hye Jin Choi, Arndt Vogel, Michael J Pishvaian, Lipika Goyal, Makoto Ueno, Angela Märten, Michael Teufel, Lijiang Geng, Chigusa Morizane. Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors. Future Oncology 2024; 20(16): 1069 doi: 10.2217/fon-2023-0963
|
| 99 |
Victoria Spadafora, Benjamin R. Pryce, Alexander Oles, Erin E. Talbert, Martin Romeo, Silvia Vaena, Stefano Berto, Michael C. Ostrowski, David J. Wang, Denis C. Guttridge. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12104-0
|
| 100 |
Silviu Stanciu, Florentina Ionita-Radu, Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga. Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects. International Journal of Molecular Sciences 2022; 23(17): 10132 doi: 10.3390/ijms231710132
|
| 101 |
Christos Vallilas, Panagiotis Sarantis, Anastasios Kyriazoglou, Evangelos Koustas, Stamatios Theocharis, Athanasios G. Papavassiliou, Michalis V. Karamouzis. Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules. International Journal of Molecular Sciences 2021; 22(2): 493 doi: 10.3390/ijms22020493
|
| 102 |
Dixon J. Atkins, Jonah M. Rosas, Lisa K. Månsson, Nima Shahverdi, Siddharth S. Dey, Angela A. Pitenis. Survival-Associated Cellular Response Maintained in Pancreatic Ductal Adenocarcinoma (PDAC) Switched Between Soft and Stiff 3D Microgel Culture. ACS Biomaterials Science & Engineering 2024; 10(4): 2177 doi: 10.1021/acsbiomaterials.3c01079
|
| 103 |
Jiawei Fan, Ye Yu, Lanzhen Yan, Yuncang Yuan, Bin Sun, Dong Yang, Nan Liu, Jing Guo, Jie Zhang, Xudong Zhao. GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer. Journal of Hematology & Oncology 2023; 16(1) doi: 10.1186/s13045-023-01467-9
|
| 104 |
Hsuan‐Chen Liu, Daniel Davila Gonzalez, Dixita Ishani Viswanath, Robin Shae Vander Pol, Shani Zakiya Saunders, Nicola Di Trani, Yitian Xu, Junjun Zheng, Shu‐Hsia Chen, Corrine Ying Xuan Chua, Alessandro Grattoni. Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer. Advanced Science 2023; 10(9) doi: 10.1002/advs.202206873
|
| 105 |
Wei Yen Chan, Hao-Wen Sim, Muhammad Abdi Haryono, Desmond Yip, Venessa Chin. Immune checkpoint inhibitors for advanced pancreatic cancer. Cochrane Database of Systematic Reviews 2023; 2023(2) doi: 10.1002/14651858.CD014523
|
| 106 |
Kenneth S. Ramos, Abeer A. I. Hassanin. Environmental Oncology. 2023; : 3 doi: 10.1007/978-3-031-33750-5_1
|
| 107 |
Tao Zhang, Yu Xiang, Hang Wang, Hong Yun, Yichun Liu, Xing Wang, Hao Zhang. Radiomics Combined with Multiple Machine Learning Algorithms in Differentiating Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor: More Hands Produce a Stronger Flame. Journal of Clinical Medicine 2022; 11(22): 6789 doi: 10.3390/jcm11226789
|
| 108 |
Amber N. Habowski, Deepthi P. Budagavi, Sandra D. Scherer, Arin B. Aurora, Giuseppina Caligiuri, William F. Flynn, Ellen M. Langer, Jonathan R. Brody, Rosalie C. Sears, Giorgia Foggetti, Anna Arnal Estape, Don X. Nguyen, Katerina A. Politi, Xiling Shen, David S. Hsu, Donna M. Peehl, John Kurhanewicz, Renuka Sriram, Milagros Suarez, Sophie Xiao, Yuchen Du, Xiao-Nan Li, Nora M. Navone, Estefania Labanca, Christopher D. Willey. Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical Recommendations. Cancers 2024; 16(3): 565 doi: 10.3390/cancers16030565
|
| 109 |
Bin Li, Michael S. Nelson, Omid Savari, Agnes G. Loeffler, Kevin W. Eliceiri. Differentiation of pancreatic ductal adenocarcinoma and chronic pancreatitis using graph neural networks on histopathology and collagen fiber features. Journal of Pathology Informatics 2022; 13: 100158 doi: 10.1016/j.jpi.2022.100158
|
| 110 |
Cristian Andres Carmona-Carmona, Elisa Dalla Pozza, Giulia Ambrosini, Andrea Errico, Ilaria Dando. Divergent Roles of Mitochondria Dynamics in Pancreatic Ductal Adenocarcinoma. Cancers 2022; 14(9): 2155 doi: 10.3390/cancers14092155
|
| 111 |
Ahmad Ali, Ugo Chianese, Chiara Papulino, Antonella Toraldo, Mawada Elmagboul Abdalla Abakar, Eugenia Passaro, Rosario Cennamo, Nunzio Del Gaudio, Lucia Altucci, Rosaria Benedetti. Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma. Cancers 2022; 14(15): 3799 doi: 10.3390/cancers14153799
|
| 112 |
Francesca Ricciardiello, Laura Bergamaschi, Humberto De Vitto, Yang Gang, Taiping Zhang, Roberta Palorini, Ferdinando Chiaradonna. Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor. Cells 2021; 10(2): 431 doi: 10.3390/cells10020431
|
| 113 |
Zahra Shokati Eshkiki, Nasibeh Khayer, Atefeh Talebi, Reza Karbalaei, Abolfazl Akbari. Novel insight into pancreatic adenocarcinoma pathogenesis using liquid association analysis. BMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01174-3
|
| 114 |
Caitlyn Smith, Wei Zheng, Jixin Dong, Yaohong Wang, Jinping Lai, Xiuli Liu, Feng Yin. Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy. World Journal of Gastroenterology 2022; 28(27): 3297-3313 doi: 10.3748/wjg.v28.i27.3297
|
| 115 |
Xin Chen, Herbert J. Zeh, Rui Kang, Guido Kroemer, Daolin Tang. Cell death in pancreatic cancer: from pathogenesis to therapy. Nature Reviews Gastroenterology & Hepatology 2021; 18(11): 804 doi: 10.1038/s41575-021-00486-6
|
| 116 |
David Bauer, Lukas M. Carter, Mohamed I. Atmane, Roberto De Gregorio, Alexa Michel, Spencer Kaminsky, Sebastien Monette, Mengshi Li, Michael K. Schultz, Jason S. Lewis. 212Pb-Pretargeted Theranostics for Pancreatic Cancer. Journal of Nuclear Medicine 2024; 65(1): 109 doi: 10.2967/jnumed.123.266388
|
| 117 |
Epiphane K. Silli, Mengfei Li, Yuting Shao, Yiran Zhang, Guilin Hou, Jiaqian Du, Jingdan Liang, Ying Wang. Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer. European Journal of Pharmaceutics and Biopharmaceutics 2023; 192: 13 doi: 10.1016/j.ejpb.2023.09.014
|
| 118 |
Kimberly J. Jasmer, Kevin Muñoz Forti, Lucas T. Woods, Seunghee Cha, Gary A. Weisman. Therapeutic potential for P2Y2 receptor antagonism. Purinergic Signalling 2023; 19(2): 401 doi: 10.1007/s11302-022-09900-3
|
| 119 |
Gabrielle Wishart, Priyanka Gupta, Giuseppe Schettino, Andrew Nisbet, Eirini Velliou. 3d tissue models as tools for radiotherapy screening for pancreatic cancer. The British Journal of Radiology 2021; 94(1120) doi: 10.1259/bjr.20201397
|
| 120 |
Shuai Hao, Shuyi Xu, Liangzhu Li, Yaxian Li, Meiqi Zhao, Junsheng Chen, Shunying Zhu, Yueqing Xie, Hua Jiang, Jianwei Zhu, Mingyuan Wu. Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PD-L1 and CXCR4. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10165-7
|
| 121 |
Oluwatosin A. Saibu, Temitope M. Ajayi, Damilola A. Omoboyowa, Oladapo O. Oladipo, Sodiq O. Hammed, Tope T. Odunitan, Adenrele T. Oluwafemi, Aderonke J. Adejuyigbe, Gideon O. Aloba, Toheeb A. Balogun, Abdullahi O.Alausa, Damilola S. Bodun. Molecular mechanics and dynamics simulation of CD-47/SIRPα blockade study: A computational study on overcoming immunotherapeutic resistance in pancreatic ductal adenocarcinoma. Arabian Journal of Chemistry 2023; 16(11): 105265 doi: 10.1016/j.arabjc.2023.105265
|
| 122 |
Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, Giulia de Martino, Vanessa Desantis. Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions. Cancers 2024; 16(13): 2438 doi: 10.3390/cancers16132438
|
| 123 |
Wei Zhang, Yanwen Xu, Rongjun Guo, Peiling Zhuang, Huixia Hong, Hui Tan, Mingfeng Wang. Theranostic Bottle-Brush Polymers Tailored for Universal Solid-Tumor Targeting. ACS Nano 2024; 18(18): 11688 doi: 10.1021/acsnano.3c11755
|
| 124 |
Cameron J. Herting, Gregory B. Lesinski. Immune Strategies for Gastrointestinal Cancer. Cancer Immunotherapy 2021; 2: 3 doi: 10.1007/13905_2021_1
|
| 125 |
S. N. Gancedo, A. Sahores, N. Gómez, N. Di Siervi, M. May, A. Yaneff, M. G. de Sousa Serro, N. Fraunhoffer, N. Dusetti, J. Iovanna, C. Shayo, C. A. Davio, B. González. The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1432851
|
| 126 |
Jihoon Ko, Sujin Hyung, Sunghun Cheong, Yoojin Chung, Noo Li Jeon. Revealing the clinical potential of high-resolution organoids. Advanced Drug Delivery Reviews 2024; 207: 115202 doi: 10.1016/j.addr.2024.115202
|
| 127 |
Evangelos Koustas, Panagiotis Sarantis, Athanasios G. Papavassiliou, Michalis V. Karamouzis. The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors. Biomolecules 2020; 10(5): 666 doi: 10.3390/biom10050666
|
| 128 |
Katelin Magnan, Linford Williams, Qian Wang, Julia Meade. A Nine-Year-Old Child With Metastatic Pancreatic Adenocarcinoma. Cureus 2024; doi: 10.7759/cureus.60670
|
| 129 |
Giada Mondanelli, Martina Mandarano, Maria Laura Belladonna, Chiara Suvieri, Cristina Pelliccia, Guido Bellezza, Angelo Sidoni, Agostinho Carvalho, Ursula Grohmann, Claudia Volpi. Current Challenges for IDO2 as Target in Cancer Immunotherapy. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.679953
|
| 130 |
Yang Iris. Targeted delivery of therapeutic oligonucleotides in pancreatic cancer. Journal of Biology and Medicine 2022; 6(1): 001 doi: 10.17352/jbm.000028
|
| 131 |
Sangyeop Hyun, Daechan Park. Challenges in genomic analysis of model systems and primary tumors of pancreatic ductal adenocarcinoma. Computational and Structural Biotechnology Journal 2022; 20: 4806 doi: 10.1016/j.csbj.2022.08.064
|
| 132 |
Fionnuala Crowley, Wungki Park, Eileen M. O’Reilly. Targeting DNA damage repair pathways in pancreas cancer. Cancer and Metastasis Reviews 2021; 40(3): 891 doi: 10.1007/s10555-021-09983-1
|
| 133 |
Vinod Ganju, Gavin Marx, Scott Pattison, Nancy B. Amaro-Mugridge, Jing-Ting Zhao, Bryan R.G. Williams, Jennifer A. MacDiarmid, Himanshu Brahmbhatt. Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells. Clinical Cancer Research 2024; 30(2): 304 doi: 10.1158/1078-0432.CCR-23-1821
|
| 134 |
Shintaro Fumoto, Tsuyoshi Yamamoto, Kazuya Okami, Yuina Maemura, Chisato Terada, Asako Yamayoshi, Koyo Nishida. Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs. Pharmaceutics 2021; 13(2): 159 doi: 10.3390/pharmaceutics13020159
|
| 135 |
Mengyang Ding, Jingyu Liu, Honghui Lv, Yanlin Zhu, Yumiao Chen, Hui Peng, Sairong Fan, Xiaoming Chen. Knocking down GALNT6 promotes pyroptosis of pancreatic ductal adenocarcinoma cells through NF-κB/NLRP3/GSDMD and GSDME signaling pathway. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1097772
|
| 136 |
Bassel F. El-Rayes, Mehmet Akce. Immunotherapy in Pancreatic Cancer. Digestive Disease Interventions 2020; 4(04): 351 doi: 10.1055/s-0040-1718904
|
| 137 |
Shiyu Liu, Fan Li, Li Deng, Qiongqiong Ma, Wenyi Lu, Zhuoqian Zhao, Huanzhen Liu, Yixuan Zhou, Manli Hu, Hui Wang, Yingbin Yan, Mingfeng Zhao, Hongkai Zhang, Mingjuan Du. Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer. Molecular Therapy - Oncolytics 2023; 30: 275 doi: 10.1016/j.omto.2023.08.011
|
| 138 |
Stefania Moz, Nicole Contran, Monica Facco, Valentina Trimarco, Mario Plebani, Daniela Basso. Vitamin D Prevents Pancreatic Cancer-Induced Apoptosis Signaling of Inflammatory Cells. Biomolecules 2020; 10(7): 1055 doi: 10.3390/biom10071055
|
| 139 |
Marco Carofiglio, Marzia Conte, Luisa Racca, Valentina Cauda. Synergistic Phenomena between Iron-Doped ZnO Nanoparticles and Shock Waves Exploited against Pancreatic Cancer Cells. ACS Applied Nano Materials 2022; 5(11): 17212 doi: 10.1021/acsanm.2c04211
|
| 140 |
Sara Maher, Hesham A. Elmeligy, Tarek Aboushousha, Noha Said Helal, Yousra Ossama, Mahmoud Rady, Ahmed Mohamed A. Hassan, Manal Kamel. Synergistic immunomodulatory effect of synbiotics pre- and postoperative resection of pancreatic ductal adenocarcinoma: a randomized controlled study. Cancer Immunology, Immunotherapy 2024; 73(6) doi: 10.1007/s00262-024-03686-6
|
| 141 |
Janina Werner, Patrick Bernhard, Miguel Cosenza-Contreras, Niko Pinter, Matthias Fahrner, Prama Pallavi, Johannes Eberhard, Peter Bronsert, Felix Rückert, Oliver Schilling. Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling. Neoplasia 2023; 36: 100871 doi: 10.1016/j.neo.2022.100871
|
| 142 |
Gaurav Sheth, Shailesh R. Shah, Prabal Sengupta, Tushar Jarag, Sabbirhusen Chimanwala, Kalapatapu V. V. M. Sairam, Vaibhav Jain, Rashmi Talwar, Avinash Dhanave, Mehul Raviya, Soumya Menon, Shivangi Trivedi, Trinadha Rao Chitturi. In the Quest for Potent and Selective Malic Enzyme 3 Inhibitors for the Treatment of Pancreatic Ductal Adenocarcinoma. ACS Medicinal Chemistry Letters 2023; 14(1): 41 doi: 10.1021/acsmedchemlett.2c00369
|
| 143 |
Qi Wang, Berina Šabanović, Azhar Awada, Chiara Reina, Alexandra Aicher, Jiajia Tang, Christopher Heeschen. Single-cell omics: a new perspective for early detection of pancreatic cancer?. European Journal of Cancer 2023; 190: 112940 doi: 10.1016/j.ejca.2023.112940
|
| 144 |
Kenta Shinzawa, Daiki Kageta, Robert J. Nash, George W.J. Fleet, Tatsushi Imahori, Atsushi Kato. Azobenzene derivatives show anti-cancer activity against pancreatic cancer cells only under nutrient starvation conditions via G0/G1 cell cycle arrest. Tetrahedron 2021; 85: 132077 doi: 10.1016/j.tet.2021.132077
|
| 145 |
Manjul Rana, Rita Kansal, Mehdi Chaib, Bin Teng, Michelle Morrrison, David Neil Hayes, Ansley G. Stanfill, David Shibata, James A. Carson, Liza Makowski, Evan S. Glazer. The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF‐β receptor plus dual checkpoint inhibition maintains antitumor immune cells. Molecular Carcinogenesis 2022; 61(6): 549 doi: 10.1002/mc.23401
|
| 146 |
Zhi-gang Zhu, Lei Chen, Dong-liu Miao, Yiqi Jin, Qiong Wu. Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.941389
|
| 147 |
Jack Chen, Edward G. Lynn, Tamana R. Yousof, Hitesh Sharma, Melissa E. MacDonald, Jae Hyun Byun, Bobby Shayegan, Richard C. Austin. Scratching the Surface—An Overview of the Roles of Cell Surface GRP78 in Cancer. Biomedicines 2022; 10(5): 1098 doi: 10.3390/biomedicines10051098
|
| 148 |
Elena García-Gareta, Alejandro Calderón-Villalba, Pilar Alamán-Díez, Carlos Gracia Costa, Pedro Enrique Guerrero, Carlota Mur, Ana Rueda Flores, Nerea Olivera Jurjo, Patricia Sancho, María Ángeles Pérez, José Manuel García-Aznar. Physico-chemical characterization of the tumour microenvironment of pancreatic ductal adenocarcinoma. European Journal of Cell Biology 2024; 103(2): 151396 doi: 10.1016/j.ejcb.2024.151396
|
| 149 |
Debamitra Chakraborty, Bradley N. Mills, Jing Cheng, Ivan Komissarov, Scott A. Gerber, Roman Sobolewski. Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (MAP) Estimation. ACS Omega 2023; 8(11): 9925 doi: 10.1021/acsomega.2c07080
|
| 150 |
Valentina Giansante, Gianmarco Stati, Silvia Sancilio, Emanuela Guerra, Saverio Alberti, Roberta Di Pietro. The Dual Role of Necroptosis in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2023; 24(16): 12633 doi: 10.3390/ijms241612633
|
| 151 |
António M. Palma, Vignesh Vudatha, Maria Leonor Peixoto, Esha Madan. Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159: 203 doi: 10.1016/bs.acr.2023.02.005
|
| 152 |
Yongji Zeng, Ling Yin, Jiuli Zhou, Renya Zeng, Yi Xiao, Adrian R. Black, Tuo Hu, Pankaj K. Singh, Feng Yin, Surinder K. Batra, Fang Yu, Yuanhong Chen, Jixin Dong. MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer. Oncogene 2022; 41(31): 3859 doi: 10.1038/s41388-022-02399-3
|
| 153 |
J. Rodon Ahnert, D.S.-W. Tan, I. Garrido-Laguna, W. Harb, A. Bessudo, J.T. Beck, S. Rottey, N. Bahary, N. Kotecki, Z. Zhu, S. Deng, K. Kowalski, C. Wei, N. Pathan, R.J. Laliberte, W.A. Messersmith. Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial. ESMO Open 2023; 8(4): 101584 doi: 10.1016/j.esmoop.2023.101584
|
| 154 |
Helen B. Binang, Chamini J. Perera, Minoti V. Apte. Role of Pancreatic Tumour-Derived Exosomes and Their Cargo in Pancreatic Cancer-Related Diabetes. International Journal of Molecular Sciences 2023; 24(12): 10203 doi: 10.3390/ijms241210203
|
| 155 |
Wenting Zhu, Hang Yu, Menglei Jia, Caiyan Lin, Zhongwen Yuan, Xiaoxiao Tan, Pengke Yan. Multi-targeting liposomal codelivery of cisplatin and rapamycin inhibits pancreatic cancer growth and metastasis through stromal modulation. International Journal of Pharmaceutics 2023; 644: 123316 doi: 10.1016/j.ijpharm.2023.123316
|
| 156 |
Mahmoud Yousef, Mark W Hurd, Abdelrahman Yousef, Ethan B Ludmir, Ashwathy B Pillai, Jennifer Peterson, Eugene J Koay, Sali Albarouki, Ching-Wei Tzeng, Rebecca Snyder, Matthew H G Katz, Huamin Wang, Michael J Overman, Anirban Maitra, Shubham Pant, Brandon G Smaglo, Robert A Wolff, James Yao, John P Shen, Dan Zhao. Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. The Oncologist 2024; doi: 10.1093/oncolo/oyae182
|
| 157 |
Khandoker Usran Ferdous, Mulu Z. Tesfay, Aleksandra Cios, Randal S. Shelton, Conner Hartupee, Alicja Urbaniak, Jean Christopher Chamcheu, Michail N. Mavros, Emmanouil Giorgakis, Bahaa Mustafa, Camila C. Simoes, Isabelle R. Miousse, Alexei G. Basnakian, Omeed Moaven, Steven R. Post, Martin J. Cannon, Thomas Kelly, Bolni Marius Nagalo. Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer. Biomedicines 2024; 12(7): 1596 doi: 10.3390/biomedicines12071596
|
| 158 |
Selas T. F. Bots, Tom J. Harryvan, Christianne Groeneveldt, Priscilla Kinderman, Vera Kemp, Nadine van Montfoort, Rob C. Hoeben. Preclinical evaluation of the gorilla‐derived HAdV‐B AdV‐lumc007 oncolytic adenovirus ‘GoraVir’ for the treatment of pancreatic ductal adenocarcinoma. Molecular Oncology 2024; 18(5): 1245 doi: 10.1002/1878-0261.13561
|
| 159 |
Abdulaziz Alhussan, Nolan Jackson, Sarah Eaton, Nancy Dos Santos, Ingrid Barta, Josh Zaifman, Sam Chen, Yuen Yi C. Tam, Sunil Krishnan, Devika B. Chithrani. Lipid-Nanoparticle-Mediated Delivery of Docetaxel Prodrug for Exploiting Full Potential of Gold Nanoparticles in the Treatment of Pancreatic Cancer. Cancers 2022; 14(24): 6137 doi: 10.3390/cancers14246137
|
| 160 |
Vanessa F. Bonazzi, Lauren G. Aoude, Sandra Brosda, Julia J. Bradford, James M. Lonie, Kelly A. Loffler, Michael G. Gartside, Kalpana Patel, Pamela Mukhopadhyay, Colm Keane, Val Gebski, James G. Kench, David Goldstein, Nicola Waddell, Andrew P. Barbour. C‐reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients. Asia-Pacific Journal of Clinical Oncology 2023; doi: 10.1111/ajco.13993
|
| 161 |
Cecilia Bergonzini, Alessandro Gregori, Tessa M. S. Hagens, Vera E. van der Noord, Bob van de Water, Annelien J. M. Zweemer, Bircan Coban, Mjriam Capula, Giulia Mantini, Asia Botto, Francesco Finamore, Ingrid Garajova, Liam A. McDonnell, Thomas Schmidt, Elisa Giovannetti, Erik H. J. Danen. ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-023-02879-8
|
| 162 |
Yun Bian, Cong Liu, Qi Li, Yinghao Meng, Fang Liu, Hao Zhang, Xu Fang, Jing Li, Jieyu Yu, Xiaochen Feng, Chao Ma, Zengrui Zhao, Li Wang, Jun Xu, Chengwei Shao, Jianping Lu. Preoperative Radiomics Approach to Evaluating Tumor‐Infiltrating CD8+ T Cells in Patients With Pancreatic Ductal Adenocarcinoma Using Noncontrast Magnetic Resonance Imaging. Journal of Magnetic Resonance Imaging 2022; 55(3): 803 doi: 10.1002/jmri.27871
|
| 163 |
Olga Michel, Wojciech Szlasa, Dagmara Baczyńska, Jolanta Saczko, Mounir Tarek, Julita Kulbacka. The role of catechin in electroporation of pancreatic cancer cells – Effects on pore formation and multidrug resistance proteins. Bioelectrochemistry 2022; 147: 108199 doi: 10.1016/j.bioelechem.2022.108199
|
| 164 |
Penelope Edwards, Byung Woog Kang, Ian Chau. Targeting the Stroma in the Management of Pancreatic Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.691185
|
| 165 |
Faisal Raza, Lauren Evans, Mahzad Motallebi, Hajra Zafar, Miguel Pereira-Silva, Kalsoom Saleem, Diana Peixoto, Abbas Rahdar, Esmaeel Sharifi, Francisco Veiga, Clare Hoskins, Ana Cláudia Paiva-Santos. Liposome-based diagnostic and therapeutic applications for pancreatic cancer. Acta Biomaterialia 2023; 157: 1 doi: 10.1016/j.actbio.2022.12.013
|
| 166 |
Gertrud Forika, Eva Kiss, Gabor Petovari, Titanilla Danko, Aron Bertram Gellert, Tibor Krenacs. Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines. Pathology and Oncology Research 2021; 27 doi: 10.3389/pore.2021.1610048
|
| 167 |
Kexin Li, Qingji Huo, Bai-Yan Li, Hiroki Yokota. The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs). Proteomes 2023; 11(1): 5 doi: 10.3390/proteomes11010005
|
| 168 |
Mohammad Mazharul Islam, Andrea Goertzen, Pankaj K. Singh, Rajib Saha. Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modeling. iScience 2022; 25(6): 104483 doi: 10.1016/j.isci.2022.104483
|
| 169 |
Yoo Na Kim, Ketki Patil, Jeonghwa Ma, Griffin A. Dufek, S. Balakrishna Pai. Multifaceted Effects of Kinase Inhibitors on Pancreatic Cancer Cells Reveals Pivotal Entities with Therapeutic Implications. Biomedicines 2023; 11(6): 1716 doi: 10.3390/biomedicines11061716
|
| 170 |
Kyle D. G. Saunders, Johanna von Gerichten, Holly-May Lewis, Priyanka Gupta, Matt Spick, Catia Costa, Eirini Velliou, Melanie J. Bailey. Single-Cell Lipidomics Using Analytical Flow LC-MS Characterizes the Response to Chemotherapy in Cultured Pancreatic Cancer Cells. Analytical Chemistry 2023; 95(39): 14727 doi: 10.1021/acs.analchem.3c02854
|
| 171 |
Bin Li, Junyi Wang, Jing Liao, Minghui Wu, Xiangshu Yuan, Hezhi Fang, Lijun Shen, Minghua Jiang. YY1 promotes pancreatic cancer cell proliferation by enhancing mitochondrial respiration. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02712-w
|
| 172 |
Tzu-Pin Lu, Chien-Hui Wu, Chia-Chen Chang, Han-Ching Chan, Amrita Chattopadhyay, Wen-Chung Lee, Chun-Ju Chiang, Hsin-Ying Lee, Yu-Wen Tien. Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillance, Epidemiology and End Results registry. Annals of Surgical Oncology 2022; 29(3): 1608 doi: 10.1245/s10434-021-11030-w
|
| 173 |
Monica Sheinin, Susanta Mondal, Kalipada Pahan. Neutralization of p40 Homodimer and p40 Monomer Leads to Tumor Regression in Patient-Derived Xenograft Mice with Pancreatic Cancer. Cancers 2023; 15(24): 5796 doi: 10.3390/cancers15245796
|
| 174 |
Diletta Piana, Federica Iavarone, Elisa De Paolis, Gennaro Daniele, Federico Parisella, Angelo Minucci, Viviana Greco, Andrea Urbani. Phenotyping Tumor Heterogeneity through Proteogenomics: Study Models and Challenges. International Journal of Molecular Sciences 2024; 25(16): 8830 doi: 10.3390/ijms25168830
|
| 175 |
Camilla Pecoraro, Beatrice Faggion, Beatrice Balboni, Daniela Carbone, Godefridus J. Peters, Patrizia Diana, Yehuda G. Assaraf, Elisa Giovannetti. GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer. Drug Resistance Updates 2021; 58: 100779 doi: 10.1016/j.drup.2021.100779
|
| 176 |
Gabriela R. Rossi, Ashley Jensen, Serina Ng, Zhirong Yin, Aimin Li, Anjan Misra, Daniel D. Von Hoff, Lewis Gruber, Misty Gruber, Haiyong Han. Advanced glycation end product (AGE) targeting antibody SIWA318H is efficacious in preclinical models for pancreatic cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-44211-6
|
| 177 |
Ang Li, Sinan Hou, Jian Chen, Yanfang Jiang. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma. Clinica Chimica Acta 2021; 518: 156 doi: 10.1016/j.cca.2021.03.020
|
| 178 |
Kaushal Kundalia, Abdul Hakeem, Michail Papoulas, Mark Mcphail, Shruthi Reddy, Praveen Peddu, Nabil Kibriya, Simon Atkinson, Andreas Prachalias, Parthi Srinivasan, Nigel Heaton, Debashis Sarker, Paul Ross, Yoh Zen, Krishna Menon. Margin ACcentuation for resectable Pancreatic cancer using Irreversible Electroporation – Results from the MACPIE-I study. European Journal of Surgical Oncology 2021; 47(10): 2571 doi: 10.1016/j.ejso.2021.05.024
|
| 179 |
Nnenna Elebo, Jones Omoshoro-Jones, Pascaline N. Fru, John Devar, Christiaan De Wet van Zyl, Barend Christiaan Vorster, Martin Smith, Stefano Cacciatore, Luiz F. Zerbini, Geoffrey Candy, Ekene Emmanuel Nweke. Serum Metabolomic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African Ancestry. Metabolites 2021; 11(10): 663 doi: 10.3390/metabo11100663
|
| 180 |
Abdulaziz Alhussan, Nicholas Palmerley, Julian Smazynski, Joanna Karasinska, Daniel J. Renouf, David F. Schaeffer, Wayne Beckham, Abraham S. Alexander, Devika B. Chithrani. Potential of Gold Nanoparticles in Current Radiotherapy Using a Co-Culture Model of Cancer Cells and Cancer Associated Fibroblasts. Cancers 2022; 14(15): 3586 doi: 10.3390/cancers14153586
|
| 181 |
Alisa B. Beydogan, Zeynep M. Coskun Yazici, Sema Bolkent. Influences of calorie restriction and lipopolysaccharide therapy on inflammation, cytokine response, and cell proliferation in pancreatic adenocarcinoma mouse model. Journal of Biochemical and Molecular Toxicology 2023; 37(2) doi: 10.1002/jbt.23250
|
| 182 |
Isabell Luisa Wahler, Alexander Damanakis, Nils Große Hokamp, Christiane Bruns, Thomas Schmidt. Therapy of Locally Advanced and Oligometastatic Pancreatic Adenocarcinoma. Cancers 2023; 15(24): 5881 doi: 10.3390/cancers15245881
|
| 183 |
Vera Skripova, Ramilia Vlasenkova, Yan Zhou, Igor Astsaturov, Ramziya Kiyamova. Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin. Molecules 2022; 27(4): 1289 doi: 10.3390/molecules27041289
|
| 184 |
Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz, William Hsieh, William Tieu, Tara L. Pukala, Alexander H. Staudacher, Eva Bezak. Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma. Cells 2022; 11(19): 2983 doi: 10.3390/cells11192983
|
| 185 |
Fatemeh Sadat Hosseini, Abdolreza Ahmadi, Prashant Kesharwani, Hossein Hosseini, Amirhossein Sahebkar. Regulatory effects of statins on Akt signaling for prevention of cancers. Cellular Signalling 2024; 120: 111213 doi: 10.1016/j.cellsig.2024.111213
|
| 186 |
Woosol Chris Hong, Da Eun Lee, Hyeon Woong Kang, Myeong Jin Kim, Minsoo Kim, Ju Hyun Kim, Sungsoon Fang, Hyo Jung Kim, Joon Seong Park. CD74 Promotes a Pro-Inflammatory Tumor Microenvironment by Inducing S100A8 and S100A9 Secretion in Pancreatic Cancer. International Journal of Molecular Sciences 2023; 24(16): 12993 doi: 10.3390/ijms241612993
|
| 187 |
Michal Zuzčák, Jan Trnka. Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review). International Journal of Oncology 2022; 61(2) doi: 10.3892/ijo.2022.5383
|
| 188 |
Ming Li, Sebastian Freeman, Janusz Franco-Barraza, Kathy Q. Cai, Amy Kim, Sha Jin, Edna Cukierman, Kaiming Ye. A bioprinted sea-and-island multicellular model for dissecting human pancreatic tumor-stroma reciprocity and adaptive metabolism. Biomaterials 2024; 310: 122631 doi: 10.1016/j.biomaterials.2024.122631
|
| 189 |
John Martin Velez-Haro, Fernando Pérez-Rodríguez, Sabina Velázquez-Márquez, Humberto Ramírez Medina, Noé Velázquez-Márquez. Pathogens Associated with the Development of Cancer in Humans. 2024; : 303 doi: 10.1007/978-3-031-62558-9_16
|
| 190 |
Da-Lai Xu, Yuan-Qing He, Bin Xiao, Yuan Si, Jian Shi, Xue-Ang Liu, Lei Tian, Qian Ren, Ya-Song Wu, Yi Zhu. A Novel Sushi-IL15-PD1 CAR-NK92 Cell Line With Enhanced and PD-L1 Targeted Cytotoxicity Against Pancreatic Cancer Cells. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.726985
|
| 191 |
Emily A. Henderson, Slawomir Lukomski, Brian A. Boone. Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1217095
|
| 192 |
Bhavana Hemantha Rao, Pavel Souček, Viktor Hlaváč. Laser Capture Microdissection: A Gear for Pancreatic Cancer Research. International Journal of Molecular Sciences 2022; 23(23): 14566 doi: 10.3390/ijms232314566
|
| 193 |
Zhiyu Zhao, Arshdeep Khurana, Frank Antony, John W. Young, Keeley G. Hewton, Zora Brough, Tianshuang Zhong, Seth J. Parker, Franck Duong van Hoa. A Peptidisc-Based Survey of the Plasma Membrane Proteome of a Mammalian Cell. Molecular & Cellular Proteomics 2023; 22(8): 100588 doi: 10.1016/j.mcpro.2023.100588
|